Israeli Pharmaceuticals & Biotech Most Popular Stocks

Kamada

Market Cap: ₪1.3b

Manufactures and sells plasma-derived protein therapeutics.

Bonus BioGroup

Market Cap: ₪274.5m

A clinical-stage biotechnology company, develops products based on tissue engineering and cell therapy.

InterCure

Market Cap: ₪258.9m

Engages in the research, cultivation, production, marketing, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally.

Kadimastem

Market Cap: ₪171.1m

A biopharmaceutical company, develops regenerative medicine therapies based on cells derived from human embryonic stem cells to treat neuro-degenerative diseases.

Rekah Pharmaceutical Industry

Market Cap: ₪132.6m

Engages in the manufacture, marketing, sale, and distribution of pharmaceuticals, cosmetics, vitamins and nutritional supplements, and medical devices in Israel.

G.F.C Green Fields Capital

Market Cap: ₪122.7m

Does not have significant operations.

Seach Medical Group

Market Cap: ₪92.5m

Manufactures and sells medicinal cannabis products worldwide.

Grace Breeding

Market Cap: ₪85.2m

An agro-tech company, develops nitrogenous and climate change stress relief products in Europe, the United States, South America, and Israel.

Matricelf

Market Cap: ₪73.7m

A biotechnology company, develops a platform for autologous tissue engineering for various medical conditions.

Clal Biotechnology Industries

Market Cap: ₪61.2m

A private equity and venture capital firm specializing in development stage, pre-clinical; incubation, seed, start-up, early venture, emerging growth, mid venture, late venture, PIPEs, and growth capital stages of financing.

BioLineRx

Market Cap: ₪58.8m

A commercial stage biopharmaceutical company, develops and commercializes therapeutics for oncology and rare diseases.

Can-Fite BioPharma

Market Cap: ₪47.3m

A clinical-stage biopharmaceutical company, develops orally bioavailable small molecule therapeutic products for the treatment of cancer, liver inflammatory diseases, and erectile dysfunction in Israel.

XTL Biopharmaceuticals

Market Cap: ₪35.3m

A biopharmaceutical company, engages in the acquisition and development of pharmaceutical drugs for the treatment of autoimmune diseases in Israel.

Evogene

Market Cap: ₪34.5m

Operates as a computational biology company in Israel, the United States, Israel, Brazil, and internationally.

Barak Investment House

Market Cap: ₪32.3m

Engages in the managing of investments in the capital market.

Tikun Olam-Cannbit Pharmaceuticals

Market Cap: ₪27.4m

Engages in the cultivation, production, marketing, storage, distribution, export and import, and sale of cannabis-based products in Israel.

Nextage Therapeutics

Market Cap: ₪26.3m

A pharmaceutical company, develops cannabinoid-based products.

Y.B Urban Renewal - Residential Development

Market Cap: ₪25.8m

Engages in the cultivation and production of medical cannabis.

BioLight Life Sciences

Market Cap: ₪19.9m

An ophthalmic company, engages in the discovery, development, and commercialization of products and product candidates that address ophthalmic conditions.

Purple Biotech

Market Cap: ₪17.5m

A clinical-stage company, focuses on developing therapies to overcome tumor immune evasion and drug resistance for cancer patients in the United States.

Blue Wave Water Capital

Market Cap: ₪10.6m

Engages in the multiplication, cultivation, production, and sale of cannabis for medical purposes.

Smart Agro -

Market Cap: ₪10.4m

Focuses on the research and development in the field of agricultural technology in Israel.

PlantArc Bio

Market Cap: ₪6.8m

Operates as an Ag-Bio company for the crop protection and yield enhancement.

Nextgen Biomed

Market Cap: ₪5.6m

Develops topical treatment for psoriasis.

HBL - Hadasit Bio-Holdings

Market Cap: ₪5.1m

Operates in the biotechnology industry in Israel.